This page shows the latest PsA news and features for those working in and with pharma, biotech and healthcare.
clearance, alongside results that demonstrated positive joint efficacy, compared to existing PsA therapies. ... Through using the NMA approach to trial data, companies like Janssen are able to provide comparative evidence of PsA therapies.
Secondary endpoints from the study showed that relugolix was better than Lupron at suppressing testosterone quickly (four to 15 days after dosing started), suppressing prostate-specific antigen PSA at day 15
CRPC, and a 52% prostate-specific antigen (PSA) response.
a 52% prostate-specific antigen (PSA) response.
J&J is already a leader in the immunology market, and recently filed its next-generation IL-23 inhibitor Tremfya in psoriatic arthritis (PsA) with the European Medicines Agency. ... loss. If it can win approval, Tremfya will become the first selective
some evidence of tumour response with a decrease in prostate-specific antigen (PSA) levels. ... Another group of patients whose PSA levels were lower but whose cancer had spread to the bone lived for an average of 14.1 months on Keytruda.
More from news
Approximately 5 fully matching, plus 37 partially matching documents found.
This is what BMS has secured with Bavarian Nordic's cancer vaccine targeting PSA in phase III for treatment of metastatic castration-resistant prostate cancer.
The phase II results showed a decline in PSA levels of more than 50% in the study of 124 patients.
The first peak was clearly the result of the introduction of PSA tests in the late 1980s; the cause of the second, smaller peak was not as definite, but researchers have ... attributed it to the publicity surrounding then-federal health minister Alan Rock
Future risk of prostate cancer is closely related to a man’s prostate-specific antigen (PSA) score; men screened at the age of 40 establish a baseline that can be tracked ... PSAs have always been a critical, controversial issue, which is why the
H&K secured Sherri Shepherd of ABC’s Emmy-winning morning talk show The View to donate her time to record radio PSAs. ... To-date, the PSA has reached more than 32 million. • A partnership with MTV garnered coverage on 16 and Pregnant and Teen Mom.
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
How do you convey the risk of false positives when screening for breast cancer, or the fact that measuring PSA has no impact on surviving prostate cancer?
A few years ago, a London garage owner who owed his life to a timely PSA test, started offering free car MOT tests to men who agreed to get their prostate
Almost a third of people with psoriasis will develop PsA but patients may experience arthritic symptomsbefore any skin manifestations. ... unclear on what signs to check for a full and complete diagnosis of PsA?
More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.